The global Inflammatory Bowel Disease Drugs market is anticipated to witness steady growth, driven by the increasing prevalence of inflammatory bowel disorders, advancements in treatment modalities, and rising healthcare investments. According to the latest market analysis by [Research Firm], the Inflammatory Bowel Disease Drugs market was valued at USD 20.55 billion in 2022. With a projected...